“…Clinical trials have detected both an increased rate of yellow-blue and blue-green deficiencies and a foveal loss of sensitivity to blue targets in glaucoma and ocular hypertension [1,4,7]. Experimental devices have proved their efficacy [1], but up to now both central testing and color perimetry performed using common clinical equipments have not succeeded in identifying early glaucomatous damage [2,8,10,14]. What is needed is a sensitive, reliable, standardized, quick and inexpensive psychophys~cal test of foveal function.…”